RNTX
Rein Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:11:46 PM EST
0.38USD+7.716%(+0.03)1,149,049
Pre-marketNov 19, 2026 9:17:30 AM EST
0.3625USD+2.837%(+0.01)
RNTX Financials
In Q3 FY 2026 (ended ), Rein Therapeutics, Inc. Common Stock (RNTX) reported revenue of $0, net income of −$5.54M, operating cash flow of −$7.27M, and assets of $59.43M (filed ).
Loading financial statements…